Trial Profile
A retrospective study of switching from darunavir/ritonavir combinaiton to cobicitast/darunavir single tablet regimen in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Darunavir/ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 30 Dec 2016 New trial record